Publicly Traded

  1. You are here:    Home
  2. Analytics
  3. Publicly Traded

Alert!

To view the full data details, please   Login  or   Register.
 
Intellectual Property
  Explanation

Synopsis: SBIR-STTR IPO Data

Publicly Traded Firms
1,003
Prog Active Firms
103
SBIR-STTR Awards
7,845
SBIR-STTR Dollars
$3.3B
VC Dollars
$101.1B
IPO+ Dollars
$97.0B
  Explanation

SBIR Index (Weekly indicator)

SBIR Index
-100.00%
04/18/2025
0 firms
Developed and maintained by Innovation Development Institute, LLC., the SBIR Index is a regularly updated indicator carried here on the site. The calculation is based on the weekly, close-of-business share price of those firms which are currently Publicly Traded and which have been and/or still are SBIR-involved.
  Explanation

Distribution of SBIR Public Firms By State

0 1 - 9 10 - 24 25 - 99 100+
  Explanation

By Agency Distribution of SBIR Public Firms

  Explanation

Firms by Stock Exchange

  Explanation

SBIR M&A by Price Paid: Public Firms vs Private

  Explanation

Featured SBIR Firm

Karyopharm Therapeutics Inc
Karyopharm Therapeutics Inc.(NASQAD:KPTI) is a publicly traded, clinical-stage pharmaceutical company headquarted in Newton, MA, with offices also in Germany. Focused on discovery and development of drugs directed against nuclear transport targets fo... see more
www.karyopharm.com | (617) 658-0600
  Explanation

SBIR Publicly Traded News

Oct 30 2024
Opus Genetics acquired, becomes public company based in NC
Aug 22 2023
Grander Closes Acquisition of PolarityTE, Inc. Assets
Apr 28 2023
Pfizer Buys Lucira Health for $36.4M Through Bankruptcy Auction
Apr 12 2023
PLx Pharma Inc. Enters into a Stalking Horse Asset Purchase Agreement to Sell VAZALORE® and Substantially All of its Assets
Jan 27 2023
RealNetworks, Inc. ("Real") completed a "going private" merger transaction
  Explanation